Clinical Trial of CD19 CAR-T Cell Therapy with non-virus Vector System

被引：0
|
作者：
Takahashi, Yoshiyuki [1 ]
机构：
[1] Nagoya Univ, Dept Pediat, Nagoya, Aichi, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY5-1
引用
收藏
页码：S3 / S3
页数：1
相关论文
共 50 条
  • [1] Toxicities of CD19 CAR-T cell immunotherapy
    Hirayama, Alexandre V.
    Turtle, Cameron J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S42 - S49
  • [2] Efficacy and safety of humanized CD19 CAR-T as a salvage therapy for recurrent CNSL of B-ALL following murine CD19 CAR-T cell therapy
    Li, Xin
    Liu, Mei-Jing
    Mou, Nan
    Yang, Zhen-Xing
    Wang, Jia
    Mu, Juan
    Zhu, Hai-Bo
    Deng, Qi
    ONCOLOGY LETTERS, 2021, 22 (05)
  • [3] CD19 CAR-T Cell Therapy: High Efficacy in Autoimmune Diseases
    Brudermanns, Britta
    TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 126 - 126
  • [4] CD19 CAR-T therapy and sepsis: dancing with the devil
    Budde, Lihua E.
    Zaia, John A.
    BLOOD, 2018, 131 (01) : 7 - 8
  • [5] Comorbidities Associated with Early Mortality after CD19 CAR-T Cell Therapy
    Tang, Kevin
    Khwaja, Raamis
    Feng, Lei
    Strati, Paolo
    Steiner, Raphael E.
    Nair, Ranjit
    Flowers, Christopher R.
    Saini, Neeraj
    Ramdial, Jeremy L.
    Srour, Samer A.
    Champlin, Richard E.
    Rondon, Gabriela
    Torres, Janet
    Kebriaei, Partow
    Nastoupil, Loretta J.
    Mistry, Haleigh
    Shpall, Elizabeth J.
    Nieto, Yago
    Westin, Jason
    Neelapu, Sattva S.
    Ahmed, Sairah
    BLOOD, 2022, 140 : 4684 - 4685
  • [6] Combating antigen escape with CD19/CD20 bispecific CAR-T cell therapy
    Zah, Eugenia
    Lin, Meng-Yin
    Jensen, Michael C.
    Silva-Benedict, Anne
    Chen, Yvonne Y.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [7] Bone Marrow Fibrosis Is Associated with Non-Response to CD19 CAR-T Therapy
    Anil, Joshua
    Lytle, Andrew
    Alnemri, Ahab
    Lockhart, Brian
    Pillai, Vinodh
    BLOOD, 2022, 140 : 9194 - 9195
  • [8] Kinetics of Immune Reconstitution after CD19 CAR-T Cell Therapy in ALL Patients
    Wang, Ying
    Cao, Jiang
    Yan Zhiling
    Qiao, Jianlin
    Li, Deipeng
    Li, Zhenyu
    Xu, Kailin
    BLOOD, 2019, 134
  • [9] A comprehensive analysis of the fatal toxic effects associated with CD19 CAR-T cell therapy
    Cai, Changjing
    Tang, Diya
    Han, Ying
    Shen, Edward
    Ahmed, Omar Abdihamid
    Guo, Cao
    Sheng, Hong
    Zeng, Shan
    AGING-US, 2020, 12 (18): : 18741 - 18753
  • [10] CD19 CAR-T Cell Therapy in Children with Relapsed and Refractory B-ALL
    Molostova, Olga
    Shelikhova, Larisa
    Muzalevsky, Yakov
    Kazachenok, Alexey
    Khismatullina, Rimma
    Abugova, Julia
    Kurnikova, Elena
    Trakhtman, Pavel
    Pershin, Dmitry
    Zubachenko, Viktoria
    Fadeeva, Maria
    Popov, Alexander M.
    Illarionova, Olga
    Miakova, Natalia
    Litvinov, Dmitry
    Novichkova, Galina
    Maschan, Alexey
    Maschan, Michael
    BLOOD, 2021, 138
12345